top of page

英語論文を38本追加しました

  • サイト管理者
  • 2024年9月28日
  • 読了時間: 3分

2024年8月30日検索分の7本、9月6日検索分の8本、9月13日検索分の10本、9月20日検索分の4本、9月27日検索分の9本の合計38本を追加しました。

日本の先生方の論文は5本です。

The associations between common neuroimaging parameters of Progressive Supranuclear Palsy in magnetic resonance imaging and non-specific inflammatory factors - pilot study

Novel tau filament folds in individuals with MAPT mutations P301L and P301T

The association of vagal atrophy with parameters of autonomic function in multiple system atrophy and progressive supranuclear palsy

An autopsy case of progressive supranuclear palsy with severe corticospinal tract degeneration

Systematic review of phenotypes in McLeod syndrome and case report of a progressive supranuclear palsy in a female carrier

Clinical Practices and Opinions toward Gastrostomy Use in Patients with Atypical Parkinsonian Syndromes: A National Survey in the UK

A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement

Cerebrospinal Fluid Total and Phosphorylated Tau Protein in Behavioral Variant Frontotemporal Dementia, Progressive Supranuclear Palsy, Corticobasal Syndrome and Non-Fluent Agrammatic Primary Progressive Aphasia: A Systematic Review and Meta-Analysis

Impact of the Anticholinergic Burden on Disease-Specific Symptoms in Parkinsonian Syndromes

Relationships between regional burden of tau pathology and age at death and disease duration in PSP

Quantitative Comparisons of Progressive Supranuclear Palsy Rating Scale Versions Using Item Response Theory

Atypical Parkinsonian Syndromes: Structural, Functional, and Molecular Imaging Features

The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy

CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders

Predictors of Care Home Admission and Survival Rate in Patients With Syndromes Associated With Frontotemporal Lobar Degeneration in Europe

Long-standing preservation of levodopa response in progressive supranuclear palsy

Clinical characteristics of Japanese patients with corticobasal degeneration

Neuroenergetic alterations in neurodegenerative diseases: A systematic review and meta-analysis of in vivo(31)P-MRS studies

Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes

Aqueous extractable nonfibrillar and sarkosyl extractable fibrillar Alzheimer's disease tau seeds have distinct properties

Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics

GPR37 processing in neurodegeneration: a potential marker for Parkinson's Disease progression rate

The value of PET/CT in the diagnosis and differential diagnosis of Parkinson's disease: a dual-tracer study

Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies

Proteolysis of tau by granzyme A in tauopathies generates fragments that are aggregation prone

Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function

Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy

Low-dose lamotrigine induces Pisa syndrome in a patient with probable corticobasal degeneration despite previous use

A human Tau expressing zebrafish model of progressive supranuclear palsy identifies Brd4 as a regulator of microglial synaptic elimination

Frontotemporal lobar degeneration changes neuronal beta-frequency dynamics during the mismatch negativity response

Assessments scales for the evaluation of health-related quality of life in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a systematic review

Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome

Abnormal Structural-Functional Coupling and MRI Alterations of Brain Network Topology in Progressive Supranuclear Palsy

Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson's disease

Four-Repeat Tau Seeding in the Skin of Patients With Progressive Supranuclear Palsy

A framework for translating tauopathy therapeutics: Drug discovery to clinical trials

A case of corticobasal syndrome possibly associated with anti-Yo antibodies

Dynamic aphasia as an early sign of corticobasal degeneration: Clinico-radio-pathological correlation


コメント


bottom of page